Neurotrophin-3-like immunoreactivity and Trk C expression in human spinal motoneurones in amyotrophic lateral sclerosis

J Neurol Sci. 1997 May 1;148(1):33-40. doi: 10.1016/s0022-510x(96)00312-7.

Abstract

We have demonstrated neurotrophin-3 (NT-3)-like immunoreactivity and tyrosine kinase C (Trk C) receptor expression in motoneurones in postmortem amyotrophic lateral sclerosis (ALS) and control human spinal cord sections. We report that NT-3-like immunoreactivity in motoneurones is decreased in ALS when compared to control tissue. Trk C is expressed in low abundance in both control and ALS motoneurones. These findings are of importance in developing therapeutic strategies for ALS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Amyotrophic Lateral Sclerosis / metabolism*
  • Female
  • Gene Expression / physiology
  • Humans
  • Immunohistochemistry
  • In Situ Hybridization
  • Male
  • Middle Aged
  • Motor Neurons / chemistry*
  • Motor Neurons / physiology
  • Nerve Growth Factors / analysis
  • Nerve Growth Factors / immunology*
  • Neurotrophin 3
  • RNA, Messenger / analysis
  • Receptor Protein-Tyrosine Kinases / genetics*
  • Receptor, trkC
  • Receptors, Nerve Growth Factor / genetics*
  • Spinal Cord / cytology*

Substances

  • Nerve Growth Factors
  • Neurotrophin 3
  • RNA, Messenger
  • Receptors, Nerve Growth Factor
  • Receptor Protein-Tyrosine Kinases
  • Receptor, trkC